Sionna Therapeutics, Inc.
SION
$17.35
$1.519.53%
NASDAQ
| 03/31/2025 | 12/31/2024 | 03/31/2024 | |||
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | ||
| Total Other Revenue | -- | -- | -- | ||
| Total Revenue | -- | -- | -- | ||
| Cost of Revenue | -- | -- | -- | ||
| Gross Profit | -- | -- | -- | ||
| SG&A Expenses | 5.99M | 3.88M | 2.93M | ||
| Depreciation & Amortization | -- | -- | -- | ||
| Other Operating Expenses | -- | -- | -- | ||
| Total Operating Expenses | 19.66M | 18.13M | 13.15M | ||
| Operating Income | -19.66M | -18.13M | -13.15M | ||
| Income Before Tax | -16.48M | -15.85M | -11.85M | ||
| Income Tax Expenses | -- | -- | -- | ||
| Earnings from Continuing Operations | -16.48M | -15.85M | -11.85M | ||
| Earnings from Discontinued Operations | -- | -- | -- | ||
| Extraordinary Item & Accounting Change | -- | -- | -- | ||
| Minority Interest in Earnings | -- | -- | -- | ||
| Net Income | -16.48M | -15.85M | -11.85M | ||
| EBIT | -19.66M | -18.13M | -13.15M | ||
| EBITDA | -19.50M | -17.97M | -12.98M | ||
| EPS Basic | -0.62 | -3.38 | -3.84 | ||
| Normalized Basic EPS | -0.39 | -2.11 | -2.40 | ||
| EPS Diluted | -0.62 | -3.38 | -3.84 | ||
| Normalized Diluted EPS | -0.39 | -2.11 | -2.40 | ||
| Average Basic Shares Outstanding | 26.60M | 4.69M | 3.08M | ||
| Average Diluted Shares Outstanding | 26.60M | 4.69M | 3.08M | ||
| Dividend Per Share | -- | -- | -- | ||
| Payout Ratio | -- | -- | -- | ||